Search research articles
Contact Us
Filters
Showing results (121-130 of 132) with videos related to
Page
of 14
Sort By:
Advances in Enzyme Regulation
|
January 1, 1985
The biochemical pharmacology of CI-920, a structurally novel antibiotic with antileukemic activity
R C Jackson, D W Fry, T J Boritzki, et al.
Investigational New Drugs
|
January 1, 1985
Dezaguanine mesylate: a new antipurine antimetabolite
W R Leopold, D W Fry, T J Boritzki, et al.
Cancer Research
|
May 1, 1984
Anticancer activity of the structurally novel antibiotic Cl-920 and its analogues
W R Leopold, J L Shillis, A E Mertus, et al.
Cancer Research
|
August 15, 1987
Pyrazoloacridines, a new class of anticancer agents with selectivity against solid tumors in vitro
J S Sebolt, S V Scavone, C D Pinter, et al.
Food and Cosmetics Toxicology
|
June 1, 1981
Subchronic effects of guar gum in rats
S L Graham, A Arnold, L Kasza, et al.
Cancer Research
|
March 1, 1981
Biochemical programs of slowly and rapidly growing human colon carcinoma xenografts
G Weber, J C Hager, M S Lui, et al.
Advances in Enzyme Regulation
|
January 1, 1984
Biochemical pharmacology of the lipophilic antifolate, trimetrexate
R C Jackson, D W Fry, T J Boritzki, et al.
Cancer Research
|
July 29, 1998
Super in vitro synergy between inhibitors of dihydrofolate reductase and inhibitors of other folate-requiring enzymes: the critical role of polyglutamylation
H M Faessel, H K Slocum, R C Jackson, et al.
Biochemical Pharmacology
|
April 1, 1985
Biochemical and antitumor activity of tiazofurin and its selenium analog (2-beta-D-ribofuranosyl-4-selenazolecarboxamide)
T J Boritzki, D A Berry, J A Besserer, et al.
Advances in Enzyme Regulation
|
January 1, 1987
Biochemical pharmacology and experimental chemotherapy studies with guanine-7-oxide, a novel purine antibiotic
R C Jackson, T J Boritzki, J A Besserer, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 132) with videos related to
Sort By:
Page
of 14
Advances in Enzyme Regulation
|
January 1, 1985
The biochemical pharmacology of CI-920, a structurally novel antibiotic with antileukemic activity
R C Jackson, D W Fry, T J Boritzki, et al.
Investigational New Drugs
|
January 1, 1985
Dezaguanine mesylate: a new antipurine antimetabolite
W R Leopold, D W Fry, T J Boritzki, et al.
Cancer Research
|
May 1, 1984
Anticancer activity of the structurally novel antibiotic Cl-920 and its analogues
W R Leopold, J L Shillis, A E Mertus, et al.
Cancer Research
|
August 15, 1987
Pyrazoloacridines, a new class of anticancer agents with selectivity against solid tumors in vitro
J S Sebolt, S V Scavone, C D Pinter, et al.
Food and Cosmetics Toxicology
|
June 1, 1981
Subchronic effects of guar gum in rats
S L Graham, A Arnold, L Kasza, et al.
Cancer Research
|
March 1, 1981
Biochemical programs of slowly and rapidly growing human colon carcinoma xenografts
G Weber, J C Hager, M S Lui, et al.
Advances in Enzyme Regulation
|
January 1, 1984
Biochemical pharmacology of the lipophilic antifolate, trimetrexate
R C Jackson, D W Fry, T J Boritzki, et al.
Cancer Research
|
July 29, 1998
Super in vitro synergy between inhibitors of dihydrofolate reductase and inhibitors of other folate-requiring enzymes: the critical role of polyglutamylation
H M Faessel, H K Slocum, R C Jackson, et al.
Biochemical Pharmacology
|
April 1, 1985
Biochemical and antitumor activity of tiazofurin and its selenium analog (2-beta-D-ribofuranosyl-4-selenazolecarboxamide)
T J Boritzki, D A Berry, J A Besserer, et al.
Advances in Enzyme Regulation
|
January 1, 1987
Biochemical pharmacology and experimental chemotherapy studies with guanine-7-oxide, a novel purine antibiotic
R C Jackson, T J Boritzki, J A Besserer, et al.
Page
of 14